Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTX and ALA as Adjunctive Therapy in CC-Resistant PCOS
NCT05231980Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Jun 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline, alpha-lipoic acid in polycystic ovary syndrome (PCOS), sponsored by Ain Shams University. Started Jun 2022; status: completed.
02
Drugs
pentoxifyllinealpha-lipoic acid
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05231980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05231980.